Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.
about
Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J miceEffect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes.Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice.Effect of glycemic control on corneal nerves and peripheral neuropathy in streptozotocin-induced diabetic C57Bl/6J mice.Effect of Treatment with Salsalate, Menhaden Oil, Combination of Salsalate and Menhaden Oil, or Resolvin D1 of C57Bl/6J Type 1 Diabetic Mouse on Neuropathic Endpoints.Mouse models of diabetic neuropathy.Alternatives to the Streptozotocin-Diabetic Rodent.Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints.Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.Effect of Inhibition or Deletion of Neutral Endopeptidase on Neuropathic Endpoints in High Fat Fed/Low Dose Streptozotocin-Treated Mice.Impaired utilization of membrane potential by complex II-energized mitochondria of obese, diabetic mice assessed using ADP recycling methodology.Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy.
P2860
Q34434392-6C8633E6-0F2A-4B2C-979B-5E6061AADE0FQ35752230-C2C90A4B-E088-4FD7-9EA5-3F30A2862BA1Q35867508-3C274C2B-C9E1-4977-BCEF-5B1B7E77A7C7Q36302451-D24916DE-E474-475A-8009-7A0BE46D6811Q37179497-7F50388E-B82B-436B-85B3-09739EF1B86FQ37330126-D2C52C44-6809-48C0-B747-06B7F0125E3BQ37655239-189384FD-67C6-4487-A162-96D3D16C9288Q38822212-8D088452-F3D0-45F5-805F-AF9A09A90D80Q41679469-2B2CC078-A810-4626-B664-5E9D1E7B7DA2Q47845721-CF8E6840-10DE-4A82-848F-195B79F53E04Q48041014-FFBB4743-F0E6-43E6-808A-BC966E32C668Q48044096-22BE6808-8966-4DA9-B8CF-ED8E5C19BB51Q49520691-CF7726AF-AC08-4FD2-A3DF-36C856116BE7
P2860
Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@ast
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@en
Vasopeptidase inhibitor ilepatril
@nl
type
label
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@ast
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@en
Vasopeptidase inhibitor ilepatril
@nl
prefLabel
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@ast
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@en
Vasopeptidase inhibitor ilepatril
@nl
P2093
P2860
P1433
P1476
Vasopeptidase inhibitor ilepat ...... d neuropathy in C57Bl/6J mice.
@en
P2093
Craig Gerard
Eric Davidson
Lawrence Coppey
P2860
P304
P356
10.1016/J.NEUROPHARM.2010.09.008
P50
P577
2010-09-16T00:00:00Z